dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Sanchez-Cerrillo, Ildefonso |
dc.contributor.author | Martin-Cofreces, Noa B |
dc.contributor.author | Martínez-Fleta, Pedro |
dc.contributor.author | de la Fuente, Hortensia |
dc.contributor.author | Buzón Gómez, María José |
dc.contributor.author | Calvet-Mirabent, Marta |
dc.contributor.author | Tsukalov, Ilya |
dc.date.accessioned | 2022-09-09T08:44:16Z |
dc.date.available | 2022-09-09T08:44:16Z |
dc.date.issued | 2022-07 |
dc.identifier.citation | Calvet-Mirabent M, Sánchez-Cerrillo I, Martín-Cófreces N, Martínez-Fleta P, de la Fuente H, Tsukalov I, et al. Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV. eBioMedicine. 2022 Jul;81:104090. |
dc.identifier.issn | 2352-3964 |
dc.identifier.uri | https://hdl.handle.net/11351/8101 |
dc.description | VIH; Immunoteràpia; Metabolisme |
dc.description.sponsorship | EMG was supported by the NIH R21 program (R21AI140930), the Ramón y Cajal Program (RYC2018-024374-I), the MINECO/FEDER RETOS program (RTI2018-097485-A-I00), by Comunidad de Madrid Talento Program (2017-T1/BMD-5396) and by Gilead becas de investigación (GLD19/00168). EMG and IDS are supported by Centro de Investigación Biomédica en Red (CIBERINF) de Enfermedades Infecciosas (CB21/13/00107). MCM was supported by NIH R21 program (R21AI140930), “La Caixa Banking Foundation (H20-00218) and Gilead becas de investigación (GLD19/00168). MJB is supported by the Miguel Servet program funded by the Spanish Health Institute Carlos III (CP17/00179), the MINECO/FEDER RETOS program (RTI2018-101082-B-100), and Fundació La Marató TV3 (201805-10FMTV3). EMG and MJB are both funded by “La Caixa Banking Foundation (H20-00218) and by REDINCOV grant from Fundació La Marató TV3. FSM was supported by SAF2017-82886-R and PDI-2020-120412RB-I00 grants from the Ministerio de Ciencia e Innovación, and HR17-00016 grant from “La Caixa Banking Foundation. HF was funded by PI21/01583 grant from Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III. MJC was supported by PID2019-104406RB-I00 from Ministerio de Ciencia e Innovación. ISC was funded by the CM21/00157 Rio-Hortega grant. IT was supported by grant for the promotion of research studies master-UAM 2021. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | eBioMedicine;81 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Infeccions per VIH - Tractament |
dc.subject | Antiretrovirals - Ús terapèutic |
dc.subject | Cèl·lules dendrítiques |
dc.subject.mesh | Dendritic Cells |
dc.subject.mesh | HIV Infections |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Anti-Retroviral Agents |
dc.title | Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.ebiom.2022.104090 |
dc.subject.decs | células dendríticas |
dc.subject.decs | infecciones por VIH |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antirretrovirales |
dc.relation.publishversion | https://doi.org/10.1016/j.ebiom.2022.104090 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Calvet-Mirabent M, Sánchez-Cerrillo I] Immunology Unit from Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa, Madrid, Spain. Universidad Autónoma de Madrid, Madrid, Spain. [Martín-Cófreces N] Immunology Unit from Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa, Madrid, Spain. Universidad Autónoma de Madrid, Madrid, Spain. Centro de Investigación Biomédica en Red Cardiovascular, CIBERCV, Madrid, Spain. [Martínez-Fleta P] Immunology Unit from Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa, Madrid, Spain. [de la Fuente H] Immunology Unit from Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa, Madrid, Spain. Centro de Investigación Biomédica en Red Cardiovascular, CIBERCV, Madrid, Spain. [Tsukalov I] Universidad Autónoma de Madrid, Madrid, Spain. [Buzón MJ] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 35665682 |
dc.identifier.wos | 000812936000007 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CP17%2F00179 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/RTI2018-101082-B-100 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |